• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 425 filed by Data Knights Acquisition Corp.

    9/25/23 9:20:51 AM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Get the next $DKDCA alert in real time by email
    425 1 tm2326834d1_8k.htm 425

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    Pursuant to Section 13 or 15(d) of
    the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): September 22, 2023

     

    DATA KNIGHTS ACQUISITION CORP.

    (Exact name of registrant as specified in its charter)

     

    Delaware

    (State or other jurisdiction of incorporation)

     

    001-40386   86-2076743
    (Commission
    File Number)
      (IRS Employer
    Identification No.)

     

    Unit G6, Frome Business Park, Manor Road

    Frome

    United Kingdom, BA11 4FN

    (Address of principal executive offices) (Zip Code)

     

    Registrant’s telephone number, including area code +44 203 833 4000

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

      x Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
         
      ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
         
      ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
         
      ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of Each Class   Trading
    Symbol(s)
      Name of Each Exchange on Which Registered
    Units, each consisting of one share of Class A Common Stock and one Redeemable Warrant   DKDCU   The Nasdaq Stock Market LLC
    Class A Common Stock, $0.0001 par value per share   DKDCA   The Nasdaq Stock Market LLC
    Redeemable Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share   DKDCW   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

    Item 8.01.Other Events.

     

    Effectiveness of Registration Statement

     

    On April 25, 2022, Data Knights Acquisition Corp., a Delaware corporation (the “Company”), Data Knights Merger Sub, Inc., a Delaware corporation (“Merger Sub”), and Data Knights, LLC, the Company’s sponsor, entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) with OneMedNet Corporation, Inc., a Delaware corporation (“OneMedNet”), and Paul Casey, as seller representative, pursuant to which MergerSub will merge into OneMedNet with OneMedNet surviving as a wholly owned subsidiary of the Company. In connection with the Merger Agreement, on July 22, 2022, the Company filed a preliminary registration statement on Form S-4 with the Securities and Exchange Commission (the “SEC”), which was further amended. On September 25, 2023, the Company and OneMedNet issued a joint press release announcing that the SEC declared the registration statement on Form S-4 effective as of September 22, 2023.

     

    A copy of the press release is attached as Exhibit 99.1 and is incorporated into this Item 8.01 by reference.

     

    Item 9.01. Exhibits.

     

    Exhibit
    Number
      Description of Exhibit  
         
    99.1   Press Release dated September 25, 2023.
    104   Cover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit)

     

     

     

     

    SIGNATURES

     

    Under the requirements of the Securities Exchange Act of 1934, the Company has caused this report to be signed the duly authorized undersigned.

     

     

    DATA KNIGHTS ACQUISITION CORP. 

       
         

    Date: September 25, 2023

    By: /s/ Barry Anderson
        Barry Anderson
        Chief Executive Officer

     

     

     

    Get the next $DKDCA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DKDCA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DKDCA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Casey Paul claimed ownership of 599,172 shares (SEC Form 3)

    3 - OneMedNet Corp (0001849380) (Issuer)

    11/15/23 4:18:48 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    New insider Kosasa Thomas claimed ownership of 4,952,409 shares (SEC Form 3)

    3 - OneMedNet Corp (0001849380) (Issuer)

    11/15/23 2:08:21 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    SEC Form 4: Owl Creek Asset Management, L.P. disposed of $5,175,450 worth of shares (465,000 units at $11.13)

    4 - Data Knights Acquisition Corp. (0001849380) (Issuer)

    8/21/23 6:18:49 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $DKDCA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    OneMedNet Network Expands with New Partnership with Large Academic Research Medical Center to Benefit its Life Science Company Clients

    ~ Partnership To Leverage Real World Data for Life Science Innovation Accelerating New Diagnostic and Treatment Solutions ~MINNEAPOLIS, MN / ACCESSWIRE / November 9, 2023 / OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet"), the leading curator of regulatory-grade imaging Real World Data ("RWD"), today announced a new partnership with a leading research medical center to accelerate and expand development of new diagnostic and treatment solutions using OneMedNet's iRWD™. Life Science innovators, including pharmaceutical, AI, medical device, and clinical research organizations, are now able to effectively use existing real world data for discovery, development, regulatory-approval, and post-mar

    11/9/23 4:15:00 PM ET
    $DKDCA
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    OneMedNet Completes Business Combination with Data Knights Acquisition Corp. to Become a Publicly Traded Company

    OneMedNet Common Stock to Trade on Nasdaq Under Ticker "ONMD" Tomorrow, Wednesday, November 8, 2023OneMedNet to Fully Embark on its Growth Strategy as it Spearheads the Imaging RWD Solution in the $400 Billion Clinical MarketMINNEAPOLIS, MN / ACCESSWIRE / November 7, 2023 / OneMedNet Corporation (NASDAQ:DKDCA)(NASDAQ:DKDCW) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Imaging Real World Data ("RWD"), through its proven OneMedNet iRWD™ solution, today announced that it has completed its previously announced business combination with Data Knights Acquisition Corp. ("Data Knights"). The business combination was approved at a special meeting of Data Knights' stockholde

    11/7/23 2:00:00 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Data Knights Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination

    MINNEAPOLIS, MN and LONDON, UK / ACCESSWIRE / October 12, 2023 / Data Knights Acquisition Corp. ("Data Knights" or the "Company") (NASDAQ:DKDCU, DKDCA, DKDCW))), a special purpose acquisition company, today announced that on October 10, 2023 it caused to be deposited $75,000 into the Company's trust account, allowing the Company to extend the period of time it has to consummate its initial business combination by one month from October 11, 2023 to November 11, 2023 (the "Extension"). The Extension is the third of nine (9) one-month extensions permitted under the Company's governing documents. Cautionary Statement Regarding Forward-Looking StatementsThis press release contains statements

    10/12/23 4:45:00 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $DKDCA
    SEC Filings

    View All

    Data Knights Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - OneMedNet Corp (0001849380) (Filer)

    2/9/24 4:15:31 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    SEC Form S-1 filed by Data Knights Acquisition Corp.

    S-1 - OneMedNet Corp (0001849380) (Filer)

    12/18/23 8:29:14 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Data Knights Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - OneMedNet Corp (0001849380) (Filer)

    11/22/23 5:30:12 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $DKDCA
    Leadership Updates

    Live Leadership Updates

    View All

    OneMedNet Appoints Healthcare IT Executive, Aaron Green, as President

    ~ Signaling a New Chapter of Growth for the Innovative Solution of Real World Data~MINNEAPOLIS, MN / ACCESSWIRE / May 23, 2023 / OneMedNet Corporation ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Imaging Real Word Data, through its proven OneMedNet iRWD™ solution, today announced the expansion of its executive team with the appointment of healthcare technology veteran, Aaron Green, as President. In this new role, Green will be responsible for all the major growth functions and lead engagement with existing clients, new clients, sales operations, marketing, communications, and product innovation, reporting directly to the CEO.Green is a healthcare technology busines

    5/23/23 4:05:00 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $DKDCA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Data Knights Acquisition Corp. (Amendment)

    SC 13G/A - OneMedNet Corp (0001849380) (Subject)

    2/14/24 6:03:43 AM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    SEC Form SC 13G/A filed by Data Knights Acquisition Corp. (Amendment)

    SC 13G/A - OneMedNet Corp (0001849380) (Subject)

    2/5/24 1:55:23 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    SEC Form SC 13G filed by Data Knights Acquisition Corp.

    SC 13G - Data Knights Acquisition Corp. (0001849380) (Subject)

    4/11/23 12:00:45 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care